Evidence map›Paper›PMID 30707107›Full record

ArticleInteractive journal of medical research2019

Internet Usage by Polish Patients With Multiple Sclerosis: A Multicenter Questionnaire Study.

Andrzej Potemkowski, Waldemar Brola, Anna Ratajczak, Marcin Ratajczak, Jacek Zaborski, Elżbieta Jasińska, Anna Pokryszko-Dragan, Ewa Gruszka, Marta Dubik-Jezierzańska, Aleksandra Podlecka-Piętowska and 11 more

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Andrzej Potemkowski *Department of Clinical Psychology and Psychoprophylaxis, University of Szczecin, Szczecin, Poland.ORCID http://orcid.org/0000-0001-8162-8649
Waldemar Brola *Institute of Physiotherapy, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland.ORCID http://orcid.org/0000-0002-7955-3454
Anna Ratajczak *Pomeranian Medical University, Szczecin, Poland.ORCID http://orcid.org/0000-0002-6442-780X
Marcin Ratajczak *Clinical Trial Centre, EuroMedis, Szczecin, Poland.ORCID http://orcid.org/0000-0003-1072-8380
Jacek Zaborski *Department of Neurology, Specialist Hospital in Międzylesie, Warsaw, Poland.ORCID http://orcid.org/0000-0001-5395-9299
Elżbieta JasińskaClinical Center, RESMEDICA, Kielce, Poland.ORCID http://orcid.org/0000-0003-0016-9896
Anna Pokryszko-Dragan *Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-5203-112X
Ewa Gruszka *Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-9800-5461
Marta Dubik-Jezierzańska *Outpatient MS Clinic, Lower Silesian Specialistic Hospital, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-6713-6389
Aleksandra Podlecka-Piętowska *Department of Neurology, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0003-3940-4662
Monika Nojszewska *Department of Neurology, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0003-4231-5636
Krystyna Gospodarczyk-Szot *Department of Neurology, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0003-0114-5941
Adam Stępień *Department of Neurology, Military Institute of Medicine, Warsaw, Poland.ORCID http://orcid.org/0000-0003-0214-4940
Katarzyna Gocyła-Dudar *Department of Neurology, Military Institute of Medicine, Warsaw, Poland.ORCID http://orcid.org/0000-0003-1153-3104
Marzena Maciągowska-Terela *Department of Neurology, Military Institute of Medicine, Warsaw, Poland.ORCID http://orcid.org/0000-0002-1764-3323
Jacek Wencel *Department of Neurology and Cerebrovascular Disorders, L Bierkowski Hospital, Poznan University of Medical Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0003-3208-8556
Radosław Kaźmierski *Department of Neurology and Cerebrovascular Disorders, L Bierkowski Hospital, Poznan University of Medical Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-9760-4884
Alina Kułakowska *Department of Neurology, Medical University of Białystok, Białystok, Poland.ORCID http://orcid.org/0000-0002-5458-2830
Katarzyna Kapica-Topczewska *Department of Neurology, Medical University of Białystok, Białystok, Poland.ORCID http://orcid.org/0000-0002-9720-3204
Witold Pawełczak *Department of Neurology, Specialist Hospital, Kalisz, Poland.ORCID http://orcid.org/0000-0003-3905-3110
Halina Bartosik-Psujek *Medical Faculty, University of Rzeszów, Rzeszów, Poland.ORCID http://orcid.org/0000-0002-2860-6456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe internet is a source of knowledge and medium widely used in services that facilitate access to information and networking. Multiple sclerosis (MS) patients find the possibility of acquiring information relating to their condition particularly rewarding.

objectiveWe aimed to identify Polish MS patients' preferences by analyzing a percentage of internet users and determining the most common search subjects and patients' approach to information on the internet. Disability connected with the condition, its duration, and other factors that influence patients' internet use were examined along with instances of relations established through the internet and their durability.

methodsThe study examined 1045 patients (731 women, 314 men) treated in 10 Polish MS centers, of whom 932 (89.19%) declared to be internet users. Their average age was 40.65 (SD 11.06) and average MS duration was 9.08 (SD 6.97) years. The study used a proprietary survey on information seeking, the range of searched subjects, and internet usage frequency.

resultsThe majority of the patients (494/932, 53.0%) used the internet 6-7 times per week and 4.3% (40/932) declared they spent minimum 2 hours per day. The most commonly searched subjects were world news (604/932, 72.9% of patients using the internet); 60.8% (504/932) searched for information on their condition, particularly for new treatment methods (562/932, 67.8%) and the course of illness (520/932, 62.7%). One's sex had no impact on internet usage (female vs male, odds ratio [OR] 1.13, 95% CI 0.72-1.77), although a patient's age might, at varying degrees. We found several significant associations using a .05 significance level: a patient with higher education used the internet 9 times more often than one with primary education (OR 8.64, 95% CI 3.31-22.57); lasting relationships increased chances of internet usage by 10-fold compared to widowers (OR 0.12, 95% CI 0.05-0.31); living in a city with a population over 100,000 increased chances by nearly 6 times compared with the countryside (OR 5.59, 95% CI 2.72-11.48); the relapsing-remitting MS type saw a 2-fold increase compared with the primary progressive MS type (OR 0.47, 95% CI 0.29-0.75); and those needing assistance were 2 times less likely to use the internet than patients who could move independently (OR 0.53, 95% CI 0.31-0.89). More than half of the patients (489/932, 52.5%) did not discuss the information found on the internet with their neurologists; 15.9% (148/932) believed that relationships established through the internet can be stable.

conclusionsThe majority of Polish patients use the internet as a crucial information source on their condition and innovative treatment methods. The internet can be helpful in establishing new relationships, which are usually short-lived. Polish patients do not frequently discuss the information gathered on the internet with their doctors.

Indexed as

doctor-patient relationshipinformation seekinginternetmultiple sclerosis

Identifiers

PMID30707107
PMCPMC6376336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.